Tailoring nanoparticle designs to target cancer based on tumor pathophysiology

Proceedings of the National Academy of Sciences of the United States of America
Edward A SykesWarren C W Chan

Abstract

Nanoparticles can provide significant improvements in the diagnosis and treatment of cancer. How nanoparticle size, shape, and surface chemistry can affect their accumulation, retention, and penetration in tumors remains heavily investigated, because such findings provide guiding principles for engineering optimal nanosystems for tumor targeting. Currently, the experimental focus has been on particle design and not the biological system. Here, we varied tumor volume to determine whether cancer pathophysiology can influence tumor accumulation and penetration of different sized nanoparticles. Monte Carlo simulations were also used to model the process of nanoparticle accumulation. We discovered that changes in pathophysiology associated with tumor volume can selectively change tumor uptake of nanoparticles of varying size. We further determine that nanoparticle retention within tumors depends on the frequency of interaction of particles with the perivascular extracellular matrix for smaller nanoparticles, whereas transport of larger nanomaterials is dominated by Brownian motion. These results reveal that nanoparticles can potentially be personalized according to a patient's disease state to achieve optimal diagnostic and therapeu...Continue Reading

References

Jan 1, 1995·Magnetic Resonance Imaging·I JakobsenE K Rofstad
Sep 15, 2004·Chest·Juan P WisniveskyClaudia I Henschke
Jan 9, 2008·Trends in Pharmacological Sciences·Greg M ThurberK Dane Wittrup
Apr 30, 2008·BMC Medicine·Paolo P ProvenzanoPatricia J Keely
Apr 7, 2009·Nano Letters·Steven D PerraultWarren C W Chan
Nov 7, 2009·Journal of the American Chemical Society·Steven D Perrault, Warren C W Chan
Nov 17, 2009·Advanced Drug Delivery Reviews·Paul CherukuriSteven A Curley
Mar 6, 2010·Bioconjugate Chemistry·Taehwan NamSeo Young Jeong
Jun 22, 2010·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Xiaoxiao HeZhen Cheng
Sep 8, 2010·Biophysical Journal·Triantafyllos StylianopoulosRakesh K Jain
Nov 18, 2010·Biophysical Journal·Triantafyllos StylianopoulosRakesh K Jain
Jun 15, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·You Han Bae, Kinam Park
Dec 24, 2011·Journal of the American Chemical Society·Carl D WalkeyWarren C W Chan
Feb 22, 2012·The Journal of Cell Biology·Pengfei LuZena Werb
Apr 25, 2012·Annual Review of Biomedical Engineering·Alexandre AlbaneseWarren C W Chan
Dec 12, 2012·Mayo Clinic Proceedings·Ke-Da YuZhi-Ming Shao
Feb 22, 2013·Journal of the Royal Society, Interface·Lennart TreuelGerd Ulrich Nienhaus
Mar 2, 2013·Nature Reviews. Drug Discovery·Douglas W McMillinConstantine S Mitsiades
Aug 15, 2013·Cancer Letters·Daniel Rosenblum, Dan Peer
Sep 21, 2013·Nature·Melissa R Junttila, Frederic J de Sauvage
Jan 28, 2014·Nature Nanotechnology·Leo Y T ChouWarren C W Chan
May 16, 2014·Nature Communications·Edward A SykesWarren C W Chan
Oct 1, 2014·Proceedings of the National Academy of Sciences of the United States of America·David T DudleyStephen J Weiss

❮ Previous
Next ❯

Citations

Mar 19, 2016·Cancer Letters·Chloé RancouleCyrus Chargari
Aug 6, 2016·Trends in Biotechnology·Christina von RoemelingBetty Y S Kim
May 12, 2017·Physical Chemistry Chemical Physics : PCCP·Zhiqiang ShenYing Li
Nov 22, 2017·Scientia pharmaceutica·Mehrdad KhatamiManouchehr Khatami
Mar 25, 2018·Advanced Materials·Hyek Jin KwonTaeghwan Hyeon
Oct 12, 2017·The AAPS Journal·Bhawna SharmaPavan P Adiseshaiah
Oct 29, 2017·Proceedings of the National Academy of Sciences of the United States of America·Dong-Keun LeeDean Ho
Dec 7, 2017·Proceedings of the National Academy of Sciences of the United States of America·Anthony J TavaresWarren C W Chan
Sep 28, 2018·Artificial Cells, Nanomedicine, and Biotechnology·Adil M AllahverdiyevEmrah Şefik Abamor
Nov 22, 2018·Journal of Drug Targeting·Giovanna LolloJean-Pierre Benoit
Feb 1, 2019·Advanced Materials·Liang YanYuliang Zhao
Apr 6, 2019·Biomedical Microdevices·Prashant DograZhihui Wang
Jul 10, 2019·Proceedings of the National Academy of Sciences of the United States of America·Benjamin R KingstonWarren C W Chan
Dec 24, 2019·Nanomedicine·Faith Howard, Munitta Muthana
Aug 10, 2016·Advanced Materials·Vahid RaeesiWarren C W Chan
Jan 15, 2020·Nature Materials·Shrey SindhwaniWarren C W Chan
Apr 27, 2019·Environmental Science and Pollution Research International·Neha SharmaSalman Akhtar
Jun 6, 2020·Nanotechnology·Xiaofeng DaiKostya Ken Ostrikov
Apr 28, 2017·Annual Review of Immunology·Kole T Roybal, Wendell A Lim
Mar 20, 2019·Advanced Science·Yuanxin ChenBetty Y S Kim
Oct 3, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Iulia Ioana LunguEcaterina Andronescu
May 28, 2018·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Donglin HanXubo Yuan
Sep 6, 2017·Nanotechnology·Evgeniya GoldmanAvi Schroeder
Nov 15, 2018·Medical Sciences : Open Access Journal·Yihai LiuBin Liu
Dec 14, 2018·Frontiers in Bioengineering and Biotechnology·Antonio CervadoroStefano Luin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.